Current guidelines for treatment of well-differentiated thyroid cancer (WDTC) - are they really applicable to Switzerland?

被引:0
|
作者
Inglin, R. [1 ]
Kurmann, A. [1 ]
Candinas, D. [1 ]
Seiler, C. A. [1 ]
机构
[1] Univ Hosp Bern, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:15 / 16
页数:2
相关论文
共 50 条
  • [1] Current approaches to treatment of well-differentiated thyroid cancer
    Angelos, P
    ONCOLOGY-NEW YORK, 2002, 16 (03): : 309 - 315
  • [2] Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer
    Singer, PA
    Cooper, DS
    Daniels, GH
    Ladenson, PW
    Greenspan, FS
    Levy, EG
    Braverman, LE
    Clark, OH
    McDougall, IR
    Ain, KV
    Dorfman, SG
    ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (19) : 2165 - 2172
  • [3] Current Guidelines for Postoperative Treatment and Follow-Up of Well-Differentiated Thyroid Cancer
    Yoo, Jenny Y.
    Stang, Michael T.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (01) : 41 - +
  • [4] Radioiodine treatment of well-differentiated thyroid cancer
    Leonard Wartofsky
    Douglas Van Nostrand
    Endocrine, 2012, 42 : 506 - 513
  • [5] Radioiodine treatment of well-differentiated thyroid cancer
    Wartofsky, Leonard
    Van Nostrand, Douglas
    ENDOCRINE, 2012, 42 (03) : 506 - 513
  • [6] Current approaches to treatment of well-differentiated thyroid cancer - The Angelos article reviewed
    Fraker, DL
    ONCOLOGY-NEW YORK, 2002, 16 (03): : 318 - +
  • [7] Treatment of locally aggressive well-differentiated thyroid cancer
    Martins, AS
    Melo, GM
    Valério, JB
    Langner, E
    Lage, HT
    Tincani, AJ
    INTERNATIONAL SURGERY, 2001, 86 (04) : 213 - 219
  • [8] Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
    Iain J. Nixon
    Frank L. Palmer
    Monica M. Whitcher
    Ashok R. Shaha
    Jatin P. Shah
    Snehal G. Patel
    Ian Ganly
    Annals of Surgical Oncology, 2011, 18 : 767 - 770
  • [9] Thyroid Isthmusectomy for Well-Differentiated Thyroid Cancer
    Nixon, Iain J.
    Palmer, Frank L.
    Whitcher, Monica M.
    R. Shaha, Ashok
    Shah, Jatin P.
    Patel, Snehal G.
    Ganly, Ian
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (03) : 767 - 770
  • [10] Phase II study of sunitinib in iodine refractory, well-differentiated thyroid cancer (WDTC) and metastatic medullary thyroid carcinoma (MTC)
    Goulart, B.
    Carr, L.
    Martins, R. G.
    Eaton, K.
    Kell, E.
    Wallace, S.
    Capell, P.
    Mankoff, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)